5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.06▼ | 7.11▼ | 7.11▼ | 7.27▼ | 7.32▼ |
MA10 | 7.12▼ | 7.23▼ | 7.28▼ | 7.34▼ | 7.97▼ |
MA20 | 7.29▼ | 7.36▼ | 7.39▼ | 7.53▼ | 8.84▼ |
MA50 | 7.42▼ | 7.41▼ | 7.41▼ | 8.30▼ | N/A |
MA100 | 7.43▼ | 7.29▼ | 7.53▼ | 8.97▼ | N/A |
MA200 | 7.37▼ | 8.12▼ | 8.16▼ | 7.41▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.028▼ | -0.047▼ | -0.055▼ | -0.005▼ | -0.369▼ |
RSI | 22.032▼ | 24.344▼ | 28.307▼ | 38.189▼ | 43.818▼ |
STOCH | 4.467▼ | 2.739▼ | 1.937▼ | 52.303 | 26.525 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -64.970 | -86.942▼ |
CCI | -124.751▼ | -136.444▼ | -140.158▼ | -84.769 | -119.025▼ |
Saturday, October 11, 2025 11:53 PM
Detailed price information for Alpha Cognition Inc (ACOG-Q) from The Globe and Mail including charting and trades.
|
Tuesday, September 30, 2025 08:33 PM
Alpha Cognition Inc. (Nasdaq: ACOG) (the "Company"), a commercial-stage biopharmaceutical company dedicated to developing innovative treatments for neurodegenerative diseases, today announced the ...
|
Tuesday, September 30, 2025 02:44 PM
Investing.com -- Alpha Cognition Inc. (NASDAQ:ACOG) stock tumbled 12.4% in after-hours trading Tuesday after the biopharmaceutical company announced plans for a public offering of common shares and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
14/10/25 | 6.985 | 6.985 | 6.985 | 6.985 | 10,825 |
13/10/25 | 7.05 | 7.32 | 6.7954 | 7.045 | 88,800 |
10/10/25 | 7.63 | 7.80 | 7.005 | 7.02 | 59,600 |
09/10/25 | 7.72 | 7.72 | 7.355 | 7.57 | 87,800 |
08/10/25 | 7.36 | 7.78 | 7.36 | 7.72 | 185,100 |
07/10/25 | 7.45 | 7.54 | 7.27 | 7.35 | 39,100 |
06/10/25 | 7.56 | 7.618 | 7.343 | 7.40 | 146,400 |
03/10/25 | 7.41 | 7.54 | 7.28 | 7.48 | 54,600 |
02/10/25 | 7.40 | 7.78 | 7.045 | 7.44 | 93,513 |
01/10/25 | 6.91 | 7.8392 | 6.6886 | 7.37 | 252,037 |
|
|
||||
|
|
||||
|
|